Earnings Feed
Start Free
Royalty Pharma plc·4

Nov 7, 4:19 PM ET

Legorreta Pablo G. 4

4 · Royalty Pharma plc · Filed Nov 7, 2025

Insider Transaction Report

Form 4
Period: 2025-11-05
Royalty Pharma plcRPRX
Legorreta Pablo G.
DirectorCEO, Chairman of the Board
Transactions
  • Award

    Class A Ordinary Shares

    2025-11-05+36,559→ 940,955 total
Holdings

  • Class A Ordinary Shares

    (indirect: By Spouse)
    6,930

  • Class A Ordinary Shares

    (indirect: By Trust)
    1,040,410

  • Class A Ordinary Shares

    (indirect: By Trust)
    901,590

  • Class A Ordinary Shares

    (indirect: By Trust)
    600,000

  • Class A Ordinary Shares

    (indirect: By LLC)
    460,139

  • Class A Ordinary Shares

    (indirect: By Tata MC 35 Ltd.)
    292,190

  • Class A Ordinary Shares

    (indirect: By IRRA)
    123,310

  • Class A Ordinary Shares

    (indirect: By IRA)
    118,500

  • Class A Ordinary Shares

    (indirect: By Trust)
    41,306

  • Class A Ordinary Shares

    (indirect: By Son)
    10,000

  • Class A Ordinary Shares

    (indirect: By Daughter)
    10,000
Footnotes (1)
  • [F1]Reflects the exempt acquisition by the Reporting Person pursuant to Rule 16b-3 of Class A Ordinary Shares of the Issuer in connection with the settlement of Equity Performance Awards.

Documents

1 file
  • 4
    wk-form4_1762550365.xmlPrimary

    FORM 4